Authors
Latest:
Prospect of Psychedelic Therapies in Psychiatry, with Gus Alva, MDIn this part of our 5-part series, Gus Alva, MD discusses the next steps in research for long-term effects and broader applications of MDMA-assisted therapy.
Latest:
Sick Day Rules in Nephrology, with Kim Zuber, PA-C, and Jane Davis, DNPIn their latest column, Kim Zuber, PA-C, and Jane Davis, DNP, break down the concept of "sick day rules" and what this means for providers caring for those with kidney disease.
Latest:
Initiating Conversations with Patients about Anti-VEGF AgentsKey opinion leaders emphasize important considerations when discussing the safety of anti-VEGF agents with patients and highlight unmet needs in nonproliferative diabetic retinopathy treatments.
Latest:
Clinical trial data on IgAN for therapiesGerald B. Appel, MD, discusses the changing treatment landscape of IgAN.
Latest:
Looking Into the Future of Lipid ManagementDr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia
Latest:
Physician Advice for Patients With SCDWally Smith, MD, shares his take-home points for patients with sickle cell disease and urges to get tested for sickle cell trait.
Latest:
Final Thoughts on the Opioid Crisis and Normalizing NaloxoneThe multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.
Latest:
Collaboration and Communication Across the Healthcare TeamThe expert panel concludes its discussion with insights on how collaboration and communication across various healthcare specialties improve the care of patients treated for iron deficiency anemia.
Latest:
Take-Home Messages for the Management of Crohn’s DiseaseExperts in gastroenterology share advice for the treatment of patients of Crohn’s disease.
Latest:
Clinical Pearls for the Management of Wet AMDA panel of eye care specialists share clinical advice and future directions for the treatment of wet AMD.
Latest:
Closing RemarksPanelists discuss how their approaches to treating patients with rheumatoid arthritis focus on personalized strategies that prioritize achieving remission while carefully monitoring safety and efficacy outcomes.
Latest:
Novel Investigational Approaches For the Treatment of Neovascular AMDDr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.
Latest:
Final Thoughts on Management of Nasal PolyposisDrs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri share takeaway thoughts on the management of nasal polyposis.
Latest:
Treating Dry Eye in The Presence of Ocular ComorbiditiesExperts discuss the management of dry eye in the presence of concurrent ocular conditions, as well as managing dry eye before undergoing cataract and refractive surgery.
Latest:
Systemic Lupus Erythematosus Treatment Advances: AnifrolumabThe rationale for using a newer monoclonal antibody therapy, anifrolumab, to manage patients with systemic lupus erythematosus.
Latest:
Injunction Letters May Reduce Clinician Overprescription of BenzodiazepinesReductions in prescribed benzodiazepines were especially noted in continuing prescriptions.
Latest:
Appropriate Guidance for CRC Screening Age, Role of Advocacy OrganizationsIn part 5 of our 5-part discussion, experts discuss their perspective on appropriate guidance for screening age and the future of CRC advocacy.
Latest:
The APAC Recap: AHA Hypertension Scientific Sessions 2024In this episode, John Giacona, PhD, PA-C, shares insights from the 2024 AHA Hypertension Scientific Sessions, focusing on primary aldosteronism and renal denervation.
Latest:
Emerging Agents for Heart Failure TreatmentJames Januzzi, MD, and Javed Butler, MD, MPH, MBA, discuss emerging agents, vericiguat and intravenous (IV) iron, in the treatment landscape for heart failure with reduced ejection fraction and advice for community physicians managing patients with heart failure.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Latest:
Key Takeaways and Prospective Treatment AdvancesDavid Hudesman, MD, Maia Kayal, MD, Miguel Regueiro, MD, Anita Afzali, MD, and Millie Long summarize their discussion of Inflammatory Bowel Disease (IBD) and discuss prospective advances in treatment options.
Latest:
Optimizing the Management of TRDAn expert panel shares insight on the future treatment landscape for treatment-resistant depression.
Latest:
Schizophrenia: Practice, Patients, and TreatmentA panel of experts in schizophrenic psychiatric care share their thoughts on the practice, patients, and treatment based on their years of experience.
